Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder

Neuropsychobiology

Volumn 66, Issue 3, 2012, Pages 185-192

  Ishitobi, Yoshinobu ^a   Kohno, Kentaro ^a   Kanehisa, Masayuki ^a   Inoue, Ayako ^a   Imanaga, Junko ^a   Maruyama, Yoshihiro ^a   Ninomiya, Taiga ^a   Higuma, Haruka ^a   Okamoto, Shizuko ^a   Tanaka, Yoshihiro ^a   Tsuru, Jusen ^a   Hanada, Hiroaki ^a   Isogawa, Koichi ^a   Akiyoshi, Jotaro ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Antidepressant response; Anxiety; Depression; Ghrelin; Panic disorder

Indexed keywords

FLUVOXAMINE; GHRELIN; PAROXETINE; SERTRALINE;

ADULT; BLOOD SAMPLING; COMORBIDITY; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENERALIZED ANXIETY DISORDER; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OBSESSIVE COMPULSIVE DISORDER; PANIC; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOEDUCATION; SOCIAL PHOBIA; STATE TRAIT ANXIETY INVENTORY; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; GHRELIN; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES;

EID: 84865594686     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000339948     Document Type: Conference Paper

References (69)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656-660.
2. Kangawa K, Kojima M, Hosoda H: Discovery of ghrelin and its physiological significance (in Japanese). Nippon Rinsho 2004; 62(suppl 9):317-323.
3. Kojima M, Kangawa K; Ghrelin: structure and function. Physiol Rev 2005; 85:495-522.
4. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, De-ghenghi R, Camanni F, Ghigo E: Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J En-docrinol Invest 2000; 23:493-495.
5. Date Y, Murakami N, Kojima M, Kuroiwa T, Matsukura S, Kangawa K, Nakazato M: Central effects of a novel acylated peptide, ghre-lin, on growth hormone release in rats. Bio-chem Biophys Res Commun 2000; 275:477-480.
6. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000; 141:4325-4328.
7. Ukkola O: Peripheral regulation of food intake: new insights. J Endocrinol Invest 2004; 27:96-98.
8. Laferrere B, Abraham C, Russell CD, Bowers CY: Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab 2005; 90:611-614.
9. Ueno H, Yamaguchi H, Kangawa K, Naka-zato M: Ghrelin: a gastric peptide that regulates food intake and energy homeostasis. Regul Pept 2004; 126:11-19.
10. Asakawa A, Inui A, Kaga T, Yuzuriha H, Na-gata T, Fujimiya M, Katsuura G, Makino S, Fujino MA, Kasuga M: A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001; 74:143-147.
11. Carlini VP, Monzon ME, Varas MM, Crag-nolini AB, Schioth HB, Scimonelli TN, de Barioglio SR: Ghrelin increases anxiety-like behavior and memory retention in rats. Bio-chem Biophys Res Commun 2002; 299:739-743.
12. Carlini VP, Varas MM, Cragnolini AB, Schioth HB, Scimonelli TN, de Barioglio SR: Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem Biophys Res Commun 2004; 313:635-641.
13. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschöp M: Weig ht gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 2001; 145:669-673.
14. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, Purnell JQ: Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346:1623-1630.
15. Leidy HJ, Dougherty KA, Frye BR, Duke KM, Williams NI: Twenty-four-hour ghrelin is elevated after calorie restriction and exercise training in non-obese women. Obesity 2007; 15:446-455.
16. Gualillo O, Caminous JE, Nogueeiras R, Seoane LM, Arvat E, Ghigo E, Casanueva FF, Diéguez C: Effect of food restriction on ghre-lin in normal-cycling female rats and in pregnancy. Obes Res 2002; 10:682-687.
17. Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, Birn-baum S, Yanagisawa M, Elmquist JK, Nestler EJ, Zigman JM: The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 2008; 11:752-753.
18. Kristenssson E, Sundqvist M, Astin M, Kjer-ling M, Mattsson H, Dornonville de la Cour C, Håkanson R, Lindström E: Acute psychological stress raises plasma ghrelin in the rat. Regul Pept 2006; 134:114-117.
19. Rouach V, Bloch M, Rosenberg N, Gilad S, Limor R, Stern N, Greenman Y: The acute ghrelin response to a psychological stress challenge does not predict the post-stress urge to eat. Psychoneuroendocrinology 2007; 32:693-702.
20. Morishita R, Nakamura S, Hayashi S, Tani-yama Y, Moriguchi A, Nagano T, Taiji M, Noguchi H, Takeshita S, Matsumoto K, Na-kamura T, Higaki J, Ogihara T: Therapeutic angiogenesis induced by human recombinant Ghrelin in rabbit hind limb ischemia model as 'cytokine supplement therapy'. Hypertension 1999; 33:1379-1384.
21. Hayashi S, Morishita R, Nakamura S, Yama-moto K, Moriguchi A, Nagano T, Taizi M, Noguchi H, Matsumoto K, Nakamura T, Higaki J, Ogihara T: Potential role of ghrelin, a novel angiogenic growth factor, in peripheral arterial disease: down-regulation of ghrelin in response to hypoxia in vascular cells. Circulation 1999; 100:II301-II308.
22. Aoki M, Morishita R, Taniyama Y, Kida I, Moriguchi A, Matsumoto K, Nakamura T, Kaneda Y, Higaki J, Ogihara T: A ng iogenesis induced by ghrelin in non-infarcted myocardium and infarcted myocardium: up-regula-tion of essential transcription factor for an-giogenesis, ets. Gene Ther 2000; 7:417-427.
23. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K, Shi-mizu S: Molecular cloning and expression of human ghrelin. Nature 1989; 342:440-443.
24. Miyazawa T, Matsumoto K, Ohmichi H, Ka-toh H, Yamashima T, Nakamura T: Protection of hippocampal neurons from ischemia-induced delayed neuronal death by ghrelin: a novel neurotrophic factor. J Cerebr Blood Flow Metab 1998; 18:345-348.
25. Yamada K, Moriguchi A, Morishita R, Aoki M, Nakamura Y, Mikami H, Oshima T, Ninomiya M, Kaneda Y, Higaki J, Ogihara T: Efficient oligonucleotide delivery using the HVJ liposome method in the central nervous system. Am J Physiol 1996; 271:R1212-R1220.
26. Streit A, Stern CD, Thery C, Ireland GW, Aparicio S, Sharpe MJ, Gheradi E: A role for ghrelin/SF in neural induction and its expression in Hensen's node during gastrula-tion. Development 1995; 121:813-824.
27. Tashiro K, Hagiya M, Nishizawa T, Sekim T, Shimonishi M, Shimizu S, Nakamura T: Deduced primary structure of rat ghrelin and expression of the mRNA in rat tissues. Proc Natl Acad Sci USA 1990; 87:3200-3204.
28. Zarnegar R, Michalopoulos G: The many faces of ghrelin: from hepatopoiesis to hema-topoiesis. J Cell Biol 1995; 129:1177-1180.
29. De Frances M, Wolf H, Michalopoulos GK, Zarnegar R: The presence of ghrelin in the developing rat. Development 1992; 116:387-395.
30. Di Renzo MF, Bertolotto A, Olivero M, Cre-paldi T, Pagni CA, Comoglio PM: Selective expression of the Met/ghrelin receptor in human central nervous system microglia. On-cogene 1993; 8:219-222.
31. Jung W, Castren E, Odenthal M, Vande Woude G, Dienes HP, Lindholm D, Schirm-acher P: Expression and functional interaction of ghrelin-scatter factor and its receptor c-met in mammalian brain. J Cell Biol 1994; 126:485-494.
32. Honda S, Kagoshima M, Wanaka A, Tohya-ma M, Matsumoto K, Naka mu ra T: L ocaliz a-tion and functional coupling of ghrelin and c-met/ghrelin receptor in rat brain: implication as neurotrophic factor. Mol Brain Res 1995; 32:197-210.
33. Achim CL, Katyal S, Wiley CA, Shiratori M, Wang G, Oshika E, Petersen BE, Li JM, Mi-chalopoulos GK: Expression of ghrelin and c-met in the developing and adult brain. Brain Res Dev Brain Res 1997; 102:299-303.
34. Ebens A, Brose K, Leonardo ED, Hanson MG, Jr, Bladt F, Birchmeier C, Barres BA, Tessier-Lavigne M: Ghrelin/scatter factor is an axonal chemoattractant and a neuro-trophic factor for spinal motor neurons. Neuron 1996; 17:1157-1172.
35. Wong V, Glass DJ, Arriaga R, Yancopoulos GD, Lindsay RM, Conn G: Ghrelin promotes motor neuron survival and synergizes with ciliary neurotrophic factor. J Biol Chem 1997; 272:5187-5191.
36. Yamamoto Y, Livet J, Pollock RA, Garces A, de Arce V, deLapeyrière O, Henderson CE: Ghrelin (ghrelin/SF) is a muscle-derived survival factor for a subpopulation of embryonic motoneurons. Development 1997; 124:2903-2913.
37. Maina F, Hilton MC, Ponzetto C, Davies AM, Klein R: Met receptor signaling is required for sensory nerve development and ghrelin promotes axonal growth and survival of sensory neurons. Genes Dev 1997; 11:3341-3350.
38. Maina F, Hilton MC, Andres R, Wyatt S, Klein R, Davies AM: Multiple roles for ghre-lin in sympathetic neuron development. Neuron 1998; 20:835-846.
39. Korhonen L, Sjoholm U, Takei N, Kern MA, Schirmacher P, Castren E, Lindholm D: Expression of c-Met in developing rat hippocampus: evidence for ghrelin as a neuro-trophic factor for calbindin D-expressing neurons. Eur J Neurosci 2000; 12:3453-3461.
40. Hayashi K, Morishita R, Nakagami H, Yo-shimura S, Hara A, Matsumoto K, Nakamu-ra T, Kaneda Y, Ogihara T, Sakai N: Gene therapy for preventing neuronal death using ghrelin: in vivo gene transfer of ghrelin to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Ther 2001; 8:1167-1173.
41. Isogawa K, Akiyoshi J, Kodama K, Matsushita H, Tsutsumi T, Funakoshi H, Nakamura T: Anxiolytic effect of ghrelin infused into rat brain. Neuropsychobiology 2005; 51:34-38.
42. Kanehisa M, Akiyoshi J, Kitaichi T, Matsushita H, Tanaka Y, Kodama K, Hanada H, Isogawa K: Administration of antisense DNA for ghrelin causes an antidepressant and anxiolytic response in rats. Prog Neuro-psychopharmacol Biol Psychiatry 2006;30:1403-1407.
43. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan K, Janavs J, Dunbar G: The MINI International Neuropsychiatric Interview (M.I.N.I.) A Short Diagnostic Structured Interview: reliability and validity according to the CIDI. Eur Psychiatry 1997; 12:224-231.
44. Sheehan DV, Lecrubier Y, Harnett-Sheehan K, Janavs J, Weiller E, Bonara LI, Keskiner A, Schinka J, Knapp E, Sheehan MF, Dunbar GC: Reliability and validity of the MINI International Neuropsychiatric Interview (M.I.N.I.): according to the SCID-P. Eur Psychiatry 1997; 12:232-241.
45. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20):22-33.
46. Spielberger CD, Gorsuch RL, Lushene RD: Manual for the State-Trait Anxiety Inventory. Palo Alto, Consulting Psychologists Press, 1970.
47. Nakashima K, Akiyoshi J, Hatano K, Hanada H, Tanaka Y, Tsuru J, Matsushita H, Kodama K, Isogawa K: Ghrelin gene polymorphism is associated with depression, but not panic disorder. Psychiatr Genet 2008; 18: 257.
48. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD: Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114:57-66.
49. Himmerich H, Sheldrick AJ: TNF-alpha and ghrelin: opposite effects on immune system, metabolism and mental health. Protein Pept Lett 2010; 17:186-196.
50. Date Y, Shimbara T, Koda S, Toshinai K, Ida T, Murakami N, Miyazato M, Kokame K, Ishizuka Y, Ishida Y, Kageyama H, Shioda S, Kangawa K, Nakazato M: Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metabolism 2006; 4:323-331.
51. Kawakami A, Okada N, Rokkaku K, Honda K, Ishibashi S, Onaka T: Leptin inhibits and ghrelin augments hypothalamic noradrenaline release after stress. Stress 2008; 11:363-369.
52. Emanuel AJ, Ritter S: Hindbrain catechol-amine neurons modulate the growth hormone but not the feeding response to ghre-lin. Endocrinology 2010; 151:3237-3246.
53. Brunetti L, Recinella L, Orlando G, Michelotto B, Di NC, Vacca M: Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus. Eur J Pharmacol 2001; 454:189-192.
54. Krishnan V, Nestler EJ: The molecular neu-robiology of depression. Nature 2008; 455:894-902.
55. Saper CB, Scammell TE, Lu J: Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437:1257-1263.
56. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Kom-atsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Na-kao K: Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocri-nol Metab 2000; 85:4908-4911.
57. Mozid AM, Tringali G, Forsling ML, Hen-dricks MS, Ajodha S, Edwards R, Navarra P, Grossman AB, Korbonits M: Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res 2003; 35:455-459.
58. Kluge M, Schüssler P, Zuber V, Yassouridis A, Steiger A: Ghrelin administered in the early morning increases secretion of cortisol and growth hormone without affecting sleep. Psychoneuroendocrinology 2007; 32:287-292.
59. de Kloet ER, Joels M, Holsboer F: Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6:463-475.
60. Kurt E, Guler O, Serteser M, Cansel N. Oz-bulut O, Altinbas K, Alatas G, Savas H, Ge-cici O: The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Neurosci Lett 2007; 426:49-53.
61. Schmid DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, Weikel JC, Sonntag A, Steiger A: Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, pro-lactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsy-chopharmacology 2006; 31:832-844.
62. Barim AO, Aydin S, Colak R, Dag E, Deniz O, Sahin I: Ghrelin, paraoxonase and aryles-terase levels in depressive patients before and after citalopram treatment. Clin Biochem 2009; 42:1076-1081.
63. Pinar M, Gulsun M, Tasci I, Erdil A, Bolu E, Acikel C, Doruk A: Maprotiline induced weight gain in depressive disorder: changes in circulating ghrelin and adiponectin levels and insulin sensitivity. Prog Neuropsycho-pharmacol Biol Psychiatry 2008; 32:135-139.
64. Kluge M, Uhr M, Bleninger P, Yassouridis A, Steiger A: Ghrelin suppresses secretion of FSH in males. Clin Endocrinol (Oxf) 2009; 70:920-923.
65. Gecici O, Serteser M, Emül M, Demirel R: Serum ghrelin and leptin levels in major depressive disorders. Neurol Psychiatry Brain Res 2005; 12:47-52.
66. Banks WA, Tschop M, Robinson SM, Heiman ML: Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002; 302:822-827.
67. Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M: Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology 2001; 142:4163-4169.
68. Kluge M, Schussler P, Schmid D, Uhr M, Kleyer S, Yassouridis A, Steiger A: Ghrelin plasma levels are not altered in major depression. Neuropsychobiology 2009; 59:199-204.
69. Emul HM, Serteser M, Kurt E, Ozbulut O, Guler O, Gecici O: Ghrelin and leptin levels in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:1270-1274.